Fabric Genomics & GeneDx Holdings Corporation
2 shared events · Importance 3 · Last updated Aug 01, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Fabric Genomics is a wholly-owned subsidiary of GeneDx Holdings Corporation, acquired to enhance GeneDx's genomic interpretation capabilities, but has since been subject to a significant impairment loss and is central to a securities class action against its parent.
Regulatory
Fabric Genomics: Fabric Genomics is the acquired company at the center of the alleged misrepresentations. GeneDx Holdings Corporation recorded a $31.2 million impairment loss, wiping out about 94% of the cash paid for it. The acquisition's failure is the core issue in the lawsuit.
GeneDx Holdings Corporation: GeneDx Holdings Corporation is the defendant in the securities class action. The company's stock collapsed 49.2% after reporting disappointing Q1 2026 results and a $31.2 million impairment related to Fabric Genomics. The litigation and regulatory scrutiny could lead to significant financial penalties and reputational damage.
Jun 04, 2026 · 274 articles
Business
Fabric Genomics: Fabric Genomics was acquired by GeneDx Holdings Corporation, and its viability and importance were allegedly misrepresented, leading to a significant impairment loss for GeneDx Holdings Corporation and contributing to the securities fraud allegations.
GeneDx Holdings Corporation: GeneDx Holdings Corporation is the primary defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about its acquisition of Fabric Genomics and its financial prospects. Its stock price fell significantly after reporting dismal Q1 2026 results and a large impairment loss related to Fabric Genomics.
Apr 09, 2026 · 347 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Fabric Genomics and GeneDx Holdings Corporation interact across events, view sentiment trends, and discover connected entities.
Open Dashboard